Effects of Red Wine on Cardiovascular Risk Factors in Humans

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00954434

Enrollment

Registered

2009-08-07

Start date

2009-09-30

Completion date

2010-05-31

Last updated

2016-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Brief summary

Fifty healthy human subjects are randomized to not to consume any alcohol at all or to drink 1 glass of red wine/day for women or 2 glasses for men for three months. Outcomes are changes in mood, blood lipids, insulin levels, markers of inflammation and effects on liver and body composition.

Interventions

DIETARY_SUPPLEMENTred wine

intake of red wine on a daily basis

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

25 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy subjects * 25 years of age and older

Exclusion criteria

* alcoholic first degree relatives

Design outcomes

Primary

Measure	Time frame	Description
effects on laboratory variables, mood and body composition	3 months	changes in mood, blood lipids, insulin levels, markers of inflammation and effects on liver and body composition.

Secondary

Measure	Time frame
effects on liver fat amount	3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026